Our partner in Lebanon

This timeline allows you to explore a timeline highlighting some of the EU4Monitoring Drugs (EU4MD) project's achievements. As part of its ongoing commitment to strengthening cooperation and sharing expertise, EMCDDA developed the EU4Monitoring Drugs (EU4MD) project, funded by the

This report presents an analysis of the drug markets in the European Neighbourhood Policy-South region covering Algeria, Egypt, Israel, Jordan, Lebanon, Libya, Morocco, Palestine (*), Syria and Tunisia.

The European Web Survey on Drugs collected data during March and May 2021 from people who use drugs, are aged 18 or older, and live in 21 EU and 9 non-EU countries including Lebanon.

Between March and May 2021, the EU4Monitoring Drugs (EU4MD) project supported the mapping of national prevention systems in European Neighbourhood Policy (ENP) area countries.

Since the beginning of 2020, the world has been experiencing an unprecedented public health emergency caused by the coronavirus disease (COVID-19) pandemic, which has led to progressive introduction of social distancing and other control measures by national governments.

Since the beginning of 2020, the world has been experiencing an unprecedented public health emergency caused by the coronavirus disease (COVID-19) pandemic, which has led to the progressive introduction of social distancing and other control measures by national governments.